J Cosmet Med.  2020 Jun;4(1):36-40. 10.25056/JCM.2020.4.1.36.

Therapeutic efficacy of TriCell CD34⁺ cell-containing, platelet-rich plasma in alopecia patients

• Kim KB
• Kim DK

• KMID: 2561091
• DOI: http://doi.org/10.25056/JCM.2020.4.1.36

Abstract

Platelet-rich plasma (PRP) containing various growth factors and stem cells can play a role in tissue regeneration. Recently, treatments such as CD34⁺ cell-containing PRP has been used in various fields, including that of hair loss. The aim of this study was to evaluate the efficacy of CD34⁺ cell-containing PRP injections for the treatment of alopecia. We extracted PRP from the blood of 10 patients using the TriCell Platelet Concentrate System (REV-MED Technologies Corp.). TriCell CD34⁺ cell-containing PRP preparations were injected onto the scalps of 5 patients with androgenetic alopecia including 2 female patients with pattern hair loss and 3 patients with alopecia areata. There were no special side effects, and overall, hair thickness and density were improved. Three months of TriCell CD34⁺ cell-containing PRP therapy (at 4-week intervals) resulted in improved hair thickness and density in alopecia patients.

Keyword

alopecia; androgenetic alopecia; CD34⁺ cell; platelet-rich plasma therapy; TriCell platelet-rich plasma